Development and validation of novel risk prediction models of breast cancer based on stanniocalcin‐1 level-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development and validation of novel risk prediction models of breast cancer based on stanniocalcin‐1 level

Published:2022-11-06 Issue:6 Volume:12 Page:6499-6510
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Huang Sheng¹²,Chen Yuyuan²³^ORCID,Wu Jiong¹^ORCID,Chi Yayun¹^ORCID

Affiliation:

1. Department of Breast Surgery, Breast Cancer Institute Fudan University Shanghai Cancer Center, Fudan University Shanghai China

2. The 2nd Department of Breast Surgery The Third Affiliated Hospital of Kunming Medical University Kunming China

3. The Department of Thyroid and Breast Surgery The Affiliated Hospital of Ningbo University Medical College Ningbo China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5419

Reference35 articles.

1. Cancer statistics, 2022

2. Potential Therapeutic Targets in Energy Metabolism Pathways of Breast Cancer

3. Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms in breast cancer: a Sardinian preliminary case-control study

4. Molecular cloning and characterization of mouse stanniocalcin cDNA

5. Evolution and roles of stanniocalcin

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stanniocalcin-1 promotes temozolomide resistance of glioblastoma through regulation of MGMT;Scientific Reports;2024-08-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP